The publication “From inequality to resilience: the long term benefits of expanding access to insulin pumps” was prepared by Marat Mamaev with the support of the IWPR Representative Office in Central Asia and the regional analytical platform CABAR.asia.
For citation and references to the material, please indicate: Marat Mamaev, From inequality to resilience: the long term benefits of expanding access to insulin pumps, 2025, CABAR.asia.
The white paper notes that insulin pumps are recognized worldwide as an effective method for managing type 1 diabetes, reducing the incidence of complications, improving quality of life, and preventing disability. However, in Kazakhstan, the state funding program only covers children: after age 18, patients are forced to independently purchase expensive devices and consumables or return to less effective multiple-injection therapy.
International experience, including in the US, EU, Canada, Israel, and Russia, confirms that the introduction of insulin pump therapy not only reduces healthcare costs but also brings long-term benefits to the state. This is achieved through improved patient health, increased productivity, and a reduced burden of disability. The author proposes a step-by-step strategy for introducing insulin pumps in Kazakhstan: regulatory changes, a pilot project, physician training, launching a patient registry, interagency collaboration, and communication support.
‘This publication was funded by the European Union. Its contents are the sole responsibility of IWPR and do not necessarily reflect the views of the European Union.’